Gastroenterology Conferences | Hepatitis Conferences 2019 | USA Hepatology Meetings, Endoscopy Conferences Europe | Liver Disease Conferences Asia Japan Canada Middle East

Quick Links

14th Euro-Global Gastroenterology Conference

Theme: Future Perspectives and shaping trends in Gastroenterology

Gastro Congress 2019

Gastro Congress Scientfic program

Renowned Speakers

Bruce D Given
Arrowhead Pharmaceuticals, USA USA
USA

Jay-lin Jane
Iowa State University, USA USA
USA

CÃ©line Tiffon
University Hospital Bern, Switzerland Switzerland
Switzerland

Robert Rahimi
Baylor Scott and White Liver Consultants of Texas, USA
USA

Jessica Danaher
Royal Melbourne Institute of Technology University, Australia Australia
Australia

LÃ¡szlÃ³ HerszÃ©nyi
Past President of Hungarian Society of Gastroenterology , Hungary
Hungary

Dimitar tonev
Senior medical director, IQVIA, UK
UK

Lynnette Ferguson
University of Auckland School of Medicine, NewZealand New Zealand
Newzealand

Magdy El-Salhy
Professor of Gastroenterology and Hepatology at Bergen University, Norway
Norway

William J. Rowe
Former Assistant Clinical Professor of Medicine, Medical University of Ohio at Toledo, USA
USA

YAZAN ABU QWAIDER
"Texas Tech University Health Sciences Center USA"
USA

Carmen Cuffari
Johns Hopkins University USA"
USA

Oleksandr Babii
Institute of Gastroenterology of National Academy Medical Science of Ukraine Ukraine
Ukraine

Robert D. Odze
Chief, Gastrointestinal Pathology Brigham and Womens Hospital USA
USA

Errawan Wiradisuria
Indonesian Society of Endolaparoscopic Surgeons (ISES) Indonesia Indonesia"
Indonesia

Pawan Mathur
"Colorectal & Laparoscopic Surgeon, Royal Free London NHS Fundation Trust, UK
UK

Giovanni Domenico Tebala
"Consultant Gastrointestinal and Laparoscopic Surgeon, Nobles Hospital, Isle of Man"
Isle of Man

Antonio Iannetti
Honorary Member of UNIGASTRO, University â€œLa Sapienzaâ€ Roma Italy"
Italy

Ulysses Fagundes Neto
Professor, Federal University of SÃ£o Paulo (UNIFESP) Brazil"
Brazil

Giovanni Gasbarrini
"Vice-President of the International Association of Surgeons & Gastroenterologists founder and President of the ""Club del Tenue"".
Italy

Pierluigi Fracasso
"Secretary of the European Society of Primary Care Gastroenterology An affiliate of the Italian Association of Primary Care Gastroenterology.
Italy

Wolfgang Fischbach
"Chief Physician of the Medical Clinic II Professor Hospital Aschaffenburg-Alzenau.
Germany

Marco Patti
"Professor of Surgery- University of North Carolina at Chapel Hill School of Medicine Surgical Co-Director- Center for Esophageal Diseases and Swallowing USA"
USA

Davor Stimac
"Member of the Steering Committee- Croatian Gastroenterological Society University of Rijeka, Rijeka Clinical Hospital Center Croatia"
Croatia

David H. Van Thiel
"Rush Oak Park Hospital & Rush University Medical Center USA"
USA

Bashar Attar
"Chairman of Gastroenterology Cook County Health & Hospitals Professor of Medicine and Surgery at Rush University Medical Center USA"
USA

Kamal D. Mehta
"Professor- The Ohio State University College of Medicine USA"
USA

Fong-Fong Chu
"Beckman Research Institute of the City of Hope & The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology USA"
USA

Tommaso Zurleni
"Hospital of Busto Arsizio Italy "
Italy

Eduardo LondoÃ±o-Schimmer
"Member American Society of Colon and Rectal Surgeons Colombia"
Colombia

Mostafa Shalaby
"European Society of Coloprotology Member University of Rome Tor Vergata & Mansoura University Italy"
Italy

Walee Chamulitrat
"Associate Professor & Research Scientist at University Heidelberg Germany"
Germany

Gastro Congress 2019

Organizing Committee invites you to attend 14^th Euro-Global Gastroenterology Conference (Gastro Congress 2019) to be held in Zürich, Switzerland during July 08-09, 2019. The conference highlights the theme “Future Perspectives and shaping trends in Gastroenterology”.

Gastro Congress 2019 is the best platform with its well organized scientific program to the audience which includes symposiums, workshops, keynote lectures, plenary talks, panel discussions and poster sessions on latest research and technological developments in the arena as well as therapeutic aspects. The conference invites Gastroenterologists, Hepatologists, Endoscopists,Gastro Congress 2019,Internists, Physicians, Microbiologists, Virologists, Pathologists, Oncologists, Surgeons and Toxicologists, Researchers, Students, Business delegates and Young researchers across the globe.

World-renowned speakers with their ultimate talks on the most recent techniques, tactics, and the Avant grade technologies in gastrointestinal therapeutics (Gastro Congress 2019) are the hallmarks of this gastroenterology conference.

Scope of the Conference

Gastro Congress 2019 provides a great platform by gathering eminent professors, Researchers, Students and delegates to exchange new ideas. The conference will cover a wide range of topics and allow participants to discuss about the management of Gastrointestinal, liver, pancreatic diseases. Gastro Congress 2019 conference consists of keynote and plenary lectures, special sessions (Workshop and Symposium), Young Researcher Forum and Poster presentations. Best poster presenters will be judged and awarded during the conference. To encourage broad participation from all over the world Conference Series Ltd is offering reduced registration fee for students.

Conference Highlights:

Gastroenterology
Microbiota and diseases
Acid Related Diseases
Garointestinal Bleeding
Helicobacter Pylori Treatment
Neuro Gastroenterology
Gastrointestinal Cancer
Gastrointestinal Endoscopy
Clinical Advances in Liver Diseases
Gastrointestinal Pathology
Gallbladder and biliary tract Diseases
Endoscopic Innovations in Gastroenterology and surgery
Gastrointestinal Disorders and Drug Delivery
Changing Trends in Etiology of Liver diseases
Bariatric Surgery
Pediatric gastrointestinal problems
Pediatric Gastrointestinal Cancer
Esophageal disease

Conference Opportunities

For Researchers and Faculty Members:

Speaker Presentations
Gastro Congress 2019
Poster Display
Symposium hosting (4-5 member team)
Workshop organizing

For Universities, Associations & Societies:

Association Partnering
Collaboration proposals
Academic Partnering
Group Participation

For Students and Research Scholars:

Poster Competition (Winner will get Best Poster Award)
Young Researcher Forum (YRF Award to the best presenter)
Gastro Congress 2019
Student Attendee
Group registrations

For Business Delegates:

Speaker Presentations
Symposium hosting
Book Launch event
Gastro Congress 2019
networking opportunities
Audience participation

For Product Manufacturers:

Exhibitor and Vendor booths
Sponsorships opportunities
Product launch
Gastro Congress 2019
Workshop organizing
Scientific Partnering
Marketing and Networking with clients

Track 1 : Gastroenterology

Gastroenterology is the study of the normal function and diseases. It contains a complete understanding of the typical action (physiology) of the gastrointestinal organs containing the programme of material through the stomach and intestine (motility), the digestion and absorption of nutrients into the body, removal of waste from the system, and the occupation of the liver as a digestive organ. It contains common and significant disorders such as colon polyps and cancer, hepatitis, Gastroesophageal reflux (heartburn), peptic ulcer disease, colitis, gallbladder and biliary tract disease, nutritional problems, Irritable Bowel Syndrome (IBS), and pancreatitis. Increases, all common activity and disease of the digestive organs are part of the study of Gastroenterology.

Esophagus
Stomach
Small intestine
Colon and rectum
Pancreas
Gallbladder
Bile ducts
Liver

16th World Congress on Gastroenterology & Therapeutics | January 30-31, 2019 Bangkok, Thailand | 20th World Congress on Gastroenterology | March 04-05, 2019 Berlin, Germany | 21st World Congress on Advances in Gastroenterology and Hepatology | May 15-16, 2019 Mercure Melbourne Albert Park, Melbourne, Australia | Physicians Meet on Gastroenterology and Digestive Disorders Conference | August 19-20, 2019 Auckland,New Zealand | 18th International Conference on Gastroenterology and Digestive Disorders | September 16-17, 2019 Dubai, UAE | 15th Annual Congress on Gastroenterology & Hepatology | September 27-28, 2019 Hong Kong | 19th World Gastroenterologists Summit | October 14-15, 2019 Sydney, Australia | 19th International Conference on Gastroenterology and Hepatology | November 10-11, 2019 Abu Dhabi, UAE | 4th International conference on Digestive and Metabolic Diseases | October 21-22, 2019 Rome, Italy | World Summit on Liver Cirrhosis and Hepatitis | September 23-24, 2019 Tokyo, Japan | 7th International Conference on Hepatology | July 15-16, 2019 Sydney, Australia | World Liver Conference 2019 | June 17-18, 2019 Columbus, Ohio, U.S.A | 7th World Congress on Hepatitis & Liver Diseases | May 15-16, 2019 Osaka, Japan | International Metabolic Diseases and Liver Cancer Conference | May 27-28, 2019 Istanbul, Turkey | International conference on Liver and Hepatitis | April 24-25, 2019 Budapest, Hungary | World Congress on Pancreatic Cancer and Liver Diseases | January 30-31, 2019 | Radisson Hotel Narita | Tokyo, Japan

Related Associations:

European Union and UK: British Society of Gastroenterology, European Society of Gastroenterology and Endoscopy Nurses and Associates, European Society of Gastrointestinal Endoscopy, European Society for Paediatric Gastroenterology, Hepatology and Nutrition, Scottish Society of Gastroenterology, British Society of Pediatric Gastroenterology, Hepatology and Nutrition, European Society of Coloproctology, European Helicobacter and Microbiota Study Group, European Society of Neuro-gastroenterology and Motility, European Society for Diseases of the Esophagus, European Society of Comparative Gastroenterology, European Society for Primary Care Gastroenterology, Norwegian Gastroenterological Association

Track 2: Microbiota and diseases

In many complex diseases it is observed that commensal Microbiota composition is altered. Here are just some of the health conditions that involve our microbes.

Antibiotic-associated diarrhoea
Autoimmune diseases
Cancer
Diabetes
Gastric ulcers
Inflammatory bowel diseases
Obesity

Our new understanding may lead to more focused and effective treatments. Unlike modern antibiotics, which kill good microbes along with the bad, new drugs may kill only harmful bacteria while leaving the friendly ones alone. Others may nurture friendly bacteria, helping them out compete the harmful ones.â€‹

Related Associations:

Track 3: Acid Related Diseases

This is divided into 7 sections: the production of acid in the stomach, the regulation of gastric acid secretion, the pharmacology of acid secretion, the biology of acid-related diseases, gastric and duodenal ulcer disease, gastro esophageal reflux disease, and Helicobacter pylori. Each of these sections is extremely well written and provides historical insights into the various areas. For example, the first section point out that Paracelsus was one of the first to relate chemistry to disease; however, he was under the mistaken assumption that acid found in the stomach was ingested.

Section 2 presents an accounting of William Beaumont’s study of the gastric fistula in Alexis Saint Martin, which was the result of a gunshot wound. Also included in this section is the accounting of Pavlov’s delineation of vagal function in relation to the GI tract. Other important milestones of gastric physiology that are recounted include Codes’ study of the relationship of histamine to gastric secretion and the work of Bayless and Starling in identifying the hormone secretin.

In Section 2, gastric acid secretion and its neural and endocrine regulation is covered in a comprehensive manner as are all aspects of parietal cell function.

The history of the therapeutic approach to acid-related diseases is detailed in Section 3 and includes the Sippy diet, antacids, sulfated polysaccharide (sulcralfate), histamine H2 receptor antagonists, and proton pump inhibitors along with surgery.

Section 4 deals with the barrier function of the upper GI tract, intragastric pH, pepsin, intrinsic factor, and regulation of the growth of gastric epithelium.

The final section deals with Helicobacter pylori and covers its well-known history and the consequences of gastric colonization along, with the pathogenesis and treatment options

Related Associations:

Track 4: Garointestinastl Bleeding

Gastrointestinal bleeding (GI bleed), also known as gastrointestinal haemorrhage, is all forms of bleeding in the gastrointestinal tract, from the mouth to the rectum. When there is significant blood loss over a short time, symptoms may include vomiting red blood, vomiting black blood, bloody stool, or black stool.

Bleeding is typically divided into two main types: upper gastrointestinal bleeding and lower gastrointestinal bleeding. Causes of upper GI bleeds include: peptic ulcer disease, esophageal varices due to liver cirrhosis and cancer, among others. Causes of lower GI bleeds include: hemorrhoids, cancer, and inflammatory bowel disease among others.

Possible causes of GI bleeding:

Angiodysplasia: Angiodysplasia is when you have abnormal or enlarged blood vessels in your GI tract. These blood vessels can become fragile and bleed.
Benign tumors and cancer: Benign tumors and cancer in the esophagus, stomach, colon, or rectum may cause bleeding when they weaken the lining of the GI tract. A benign tumor is an abnormal tissue growth that is not cancerous.
Colitis: Ulcers in the large intestine are a complication of colitis. Ulcerative colitis is an inflammatory bowel disease that can cause GI bleeding.
Colon polyps: Colon polyps can cause GI bleeding. You can have more than one colon polyp at a time. Some types of polyps may be cancerous or can become cancerous.
Diverticular disease: Diverticular disease can cause GI bleeding when small pouches, or sacs, form and push outward through weak spots in your colon wall.
Esophageal varices: Esophageal varices can cause GI bleeding. Esophageal varices are usually related to a chronic liver condition called cirrhosis.
Esophagitis: The most common cause of esophagitis is gastro esophageal reflux (GER). GER happens when your lower esophageal sphincter is weak or relaxes when it should not. Stomach acid can damage your esophagus and cause sores and bleeding.
Gastritis: the use of non-steroidal anti-inflammatory drugs, infections, Crohn’s disease, serious illnesses, serious illnesses. If untreated, gastritis can lead to ulcers or worn-away areas of the stomach lining that can bleed in your GI tract.

Related Associations:

Track 5: Neuro Gastroenterology

Neuro-gastroenterology encloses the study of brain, It works on "brain of the gut," which is a part of the nervous system and controls motility, endocrine secretions, and microcirculation of the gastrointestinal system. the gut and their interactions in relevance to the consideration and management of gastrointestinal motility and functional gastro intestinal disorders. It mainly focuses on common Functional Gastrointestinal disorders like Irritable Bowel Syndrome, Heartburn, Abdominal Pain, Peptic Ulcer and Gallstone Pancreatitis which manages the gastrointestinal motility and Functional GIT disorders.

Gastro-intestinal motility
Gastroesophageal reflux
Gastroparesis

Related Associations:

Tracck 6: Gastrointestinal Cancer

Gastrointestinal oncology cancer is the most common cancer in the world. It is also called gastric cancer. It refers to malignant conditions of gastrointestinal GI Cancer is the most common form of cancer. The treatment of GI Cancer depends on the type of cancer, its stage, and expansion. There numerous types of GI cancer such as liver cancer, esophageal cancer, stomach cancer, Biliary tract cancer and various.

Causes

Smoking
Being overweight or obese
A diet high in smoked, pickled, or salty foods
Stomach surgery for an ulcer
Type-A blood
Epstein-Barr virus infection
Certain genes
Working in coal, metal, timber, or rubber industries
Exposure to asbestos

Related Associations:

Tracck 7: Gastrointestinal Endoscopy

Gastrointestinal Endoscopy is a technique from side to side which the doctors can be able to lookout inside the gastrointestinal track. Gastrointestinal endoscopy can be executed either an inpatient or an outpatient setting. Through this process assess the problems of the gastrointestinal track such as ulcers, Inflamed mucous, abnormal growth, bleeding in the colon. Endoscopy has various names depending on the which part of the digestive system doctor seeks to inspect.

Endoscopy
Rod-lens endoscopes
Endoscope reprocessing
Colonoscopy
Gastroscopy
Advances in Endoscopy
Augmented reality
Tools used during endoscopy

Related Associations:

Track 8: Clinical Advances in Liver Diseases

Recent biological and medical advances have clarified the mechanisms of chronic liver inflammation and succeeded in providing new therapies for various liver diseases. The aim of this issue is to summarize the current status of the basic and clinical findings in chronic liver inflammation and its complications. Such information will help develop better management programs for patients and can improve their prognosis.

Related Associations:

USA and Canada: American Gastroenterological Association, Canadian Association of Gastroenterology, North Carolina Society of Gastroenterology, Canadian Society of Gastroenterology Nurses and Associates, Florida Gastroenterological Society, Ontario Association of Gastroenterology, Alabama Gastroenterological Society, Comparative Gastroenterology Society, American Neuro-gastroenterology and Motility Society, Society of Gastroenterology Nurses and Associates (SGNA), Canadian Society of Intestinal Research, North American Society for Pediatric Gastroenterology, Hepatology and Nutrition, Colonial Gastroenterology Association

Asia-Pacific and Middle East: Gastroenterological Society of Australia, Gastroenterological Association of Thailand (GAT), Indian Society of Gastroenterology, Philippine Society of Gastroenterology, Society for Gastroenterology & Hepatology in Nigeria, Gastroenterological Society of Taiwan, Lebanese Society of Gastroenterology, Indian Association of Surgical Gastroenterology, Gastrointestinal Infection Society of India, Asian Neuro-gastroenterology and Motility Association, Bangladesh Gastroenterology Society, Gastroenterological Society of Singapore

Track 9: Gastrointestinal Pathology

Gastrointestinal pathology is the subspecialty of surgical pathology which deals with the diagnosis and characterization of neoplastic and non-neoplastic diseases of the digestive tract and accessory organs, such as the pancreas and liver.

The main purpose of the gastrointestinal tract is the transport of food and the absorption of nutrients. Many pathologic conditions of the gastrointestinal tract impair either or both of these functions. The gastrointestinal tract, and especially the colon, is a common site of malignancy. The two main symptoms related to pathology of the gastrointestinal tract are abdominal pain and gastrointestinal haemorrhage.

The four categories of the causes of acute abdominal pain are (1) inflammation, including appendicitis, cholecystitis, pancreatitis, and diverticulitis; (2) perforation; (3) obstruction; and (4) vascular disease, including acute ischemia and ruptured abdominal aortic aneurysm. The five categories of causes of chronic abdominal pain are (1) inflammation, including peptic ulcer disease, esophagitis, inflammatory bowel disease, and chronic pancreatitis; (2) vascular disease, including chronic ischemia; (3) metabolic disease, including porphyria; (4) abdominal wall pain; and (5) functional causes, including irritable bowel syndrome. The most frequent causes of chronic abdominal pain are functional.

Related Associations:

Track 10: Gallbladder and biliary tract Diseases

Gallbladder diseases considered here include gallstones, tumors, and acute acalculous cholecystitis. Gallbladder stones are an extremely common disorder and are usually asymptomatic. Some patients experience biliary colic, an intermittent and often severe pain in the epigastrium or right upper quadrant, and at times between the scapula because of temporary obstruction of the cystic duct with a gallstone. If the cystic duct obstruction persists, the gallbladder becomes inflamed and the patient develops cholecystitis, an acute inflammation and infection of the gallbladder.

Biliary tract diseases considered one of the most common causes of extra hepatic biliary obstruction is choledocholithiasis, with one or more stones in the common bile duct or common hepatic duct causing biliary obstruction. Cholangiocarcinoma is an adenocarcinoma of the intrahepatic or extra hepatic bile duct.

Related Associations:

Track 11: Endoscopic Innovations in Gastroenterology and surgery

High-definition and magnification endoscopes with electronic chromo endoscopy capability make it easier to visualize subtle lesions, such as small and flat polyps and patches of dysplastic gastrointestinal mucosa. They allow accurate characterization of polyps, which may in the future allow us to selectively resect only precancerous colonic polyps, while ignoring small benign hyperplastic polyps, which in turn will result in significant healthcare savings. New digital choledochoscopes have vastly improved diagnostic and therapeutic capabilities within the bile and pancreatic duct. Confocal endomicroscopy now allows us to perform microscopic evaluation of living tissues, improving targeted biopsies in Barrett's esophagus and aiding in the evaluation of bile duct strictures and pancreatic cysts. Similarly, technological advances in endoscopic ultrasound, optical coherence tomography and spectroscopy hold great promise for improving diagnostic and therapeutic capabilities for gastrointestinal disease.

Related Associations:

Track 12: Gastrointestinal Disorders and Drug Delivery

Gastrointestinal disorders include such conditions as constipation, irritable bowel syndrome, haemorrhoids, anal fissures, perianal abscesses, anal fistulas, perianal infections, diverticular diseases, colitis, colon polyps and cancer. Many of these can be prevented or minimized by maintaining a healthy lifestyle, practicing good bowel habits, and submitting to cancer screening.

Functional GI disorders are disorders of gut–brain interaction. It is a group of disorders classified by GI symptoms related to any combination of the following: motility disturbance, visceral hypersensitivity, altered mucosal and immune function, altered gut Microbiota, and altered central nervous system (CNS) processing. Gastrointestinal (GI) disorders, including functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis, afflict more than one in five Americans, particularly women. While some GI disorders may be controlled by diet and pharmaceutical medications, others are poorly moderated by conventional treatments. Symptoms of GI disorders often include cramping, abdominal pain, inflammation of the lining of the large and/or small intestine, chronic diarrhoea, rectal bleeding and weight loss.

Related Associations:

Track 13: Changing Trends in Etiology of Liver diseases

Related Associations:

Track 14: Bariatric surgery

Bariatric surgery (weight decrease surgery) fuses an arrangement of systems performed on people who have rich imposingness. Weight diminishment is proficient by diminishing the measure of the stomach with a gastric band or through pondering of a piece of the stomach (sleeve gastrectomy or biliopancreatic redirection with duodenal switch) or by resecting and re-directing the minute stomach related framework to an infinitesimal stomach pockets (gastric bypass surgery).

Related Associations:

Track 15: Pediatric gastrointestinal problems

Practical gastrointestinal issues are common in kids and young people with complaints of abdominal pain. Our brains and our GI tracts are firmly associated the mind and body association. The most widely recognized Pediatric common GI condition is functional stomach pain. Youngsters with this issue normally encounter intermittent agony amidst the stomach area. Medicines or treatment for functional gastrointestinal issue vary with the symptom that influences the patient most.

Related Associations:

Track 16: Pediatric Gastrointestinal Cancer

Surgeons continue their efforts to improve their techniques to operate colorectal cancers. They now have a better understanding of what makes colorectal surgery more likely to be successful, such as making sure enough lymph nodes are removed during the operation. Esophageal cancer usually begins in the cells that line the inside of the oesophagus. Pancreatic cancer begins in the tissues of your pancreas an organ in your abdomen that lies horizontally behind the lower part of your stomach. Colorectal cancer is cancer that starts in the colon or rectum. The colon and the rectum are parts of the large intestine, which is the lower part of the body’s digestive system. Pancreatic cancer is aggressive with few symptoms until the cancer is advanced. Symptoms may include abdominal pain, weight loss, diarrhoea, and jaundice. Treatments include surgery, chemotherapy, and radiation. Gallbladder cancer is a relatively uncommon cancer. If it is diagnosed early enough, it can be cured by removing the gallbladder, part of the liver and associated lymph nodes. Most often it is found after symptoms such as abdominal pain, jaundice and vomiting occur, and it has spread to other organs such as the liver.

Gastric adenocarcinoma in children
Primary pediatric gastrointestinal lymphoma
Esophageal neoplasms
Carcinoid tumors
Colorectal carcinoma
Pancreatic cancer
Anal cancer
Gallbladder cancer
New therapies of GI cancer

Related Associations:

Track 17: Esophageal disease

The esophagus is the muscular tube that carries food, and liquids from your mouth to the stomach. You may not be aware of your esophagus until you swallow something too large, too hot, or too cold. You may also notice it when something is wrong. You may feel pain or have trouble swallowing. The most common problem with the esophagus is GERD (gastro esophageal reflux disease). With GERD, a muscle at the end of your esophagus does not close properly. This allows stomach contents to leak back, or reflux, into the esophagus and irritate it. Over time, GERD can cause damage to the esophagus. Other problems include heartburn, cancer, and esophagitis. Doctors may use various tests to make a diagnosis. These include imaging tests, an upper endoscopy, and a biopsy.

The following are additional diseases and conditions that affect the esophagus:

Achalasia
Acute esophageal necrosis
Barrett's esophagus
Boerhaave syndrome
Caustic injury to the esophagus
Chagas disease
Diffuse esophageal spasm
Esophageal atresia and Tracheoesophageal fistula
Esophageal cancer
Esophageal dysphagia
Esophageal varices
Esophageal web
Esophagitis
Hiatus hernia
Jackhammer esophagus (hypercontractile peristalsis)
Killian–Jamieson diverticulum
Mallory-Weiss syndrome
Neurogenic dysphagia
Nutcracker esophagus
Schatzki's ring
Zenker's Diverticulum

Gastroesophageal Reflux disease: is a digestive disorder that affects the lower esophageal sphincter (LES), the ring of muscle between the esophagus and stomach. Many people, including pregnant women, suffer from heartburn or acid indigestion caused by GERD. Doctors believe that some people suffer from GERD due to a condition called hiatal hernia. In most cases, GERD can be relieved through diet and lifestyle changes; however, some people may require medication or surgery.

Reflux means to flow back or return. Therefore, gastro esophageal reflux is the return of the stomach's contents back up into the esophagus. In normal digestion, the lower esophageal sphincter (LES) opens to allow food to pass into the stomach and closes to prevent food and acidic stomach juices from flowing back into the esophagus. Gastroesophageal reflux occurs when the LES is weak or relaxes inappropriately, allowing the stomach's contents to flow up into the esophagus.

Related Associations:

Gastro Congress 2018 Report:

13 ^th Euro-Global Gastroenterology Conference (Gastro Congress 2018) organized by Conference Series llc LTD was held on August 20-21, 2018 at Holiday Inn Rome Aurelia, Rome, Italy. The conference highlighted the theme, “Exploring New Dimensions of Gastroenterology”. It is an annual meeting for the study of recent advancements and management of Gastroenterology disorders and diseases.

The conference was initiated with a warm welcome note for Honourable guests. Our special thanks to Dr Fong-Fong Chu, The First Affiliated Hospital - HUST, P R China and Dr Susan Joyce, Ireland, the Honourable Moderator for the conference who contributed a major part for the success of this event. The conference was marked with the presence of renowned Speakers, talented young researchers, students and business delegates driving the two days event into the path of success with thought provoking keynote and plenary presentations. Active participation and generous response were received from the Organizing Committee Members. Professors, Researchers, and Students from diverse groups made this conference as one of the most successful and productive event in 2018 from Conference Series llc LTD.

The highlights of the meeting were the enlightening Keynote lectures from:

Fong-Fong Chu, The First Affiliated Hospital - HUST, P R China on the topic, “Reactive oxygen species generated by NADPH oxidase-1 and Dual oxidase-2 contribute to inflammatory bowel disease”

Davor Štimac, Clinical Hospital Center of Rijeka - University of Rijeka, Croatia on the topic, “Endoscopic treatment of obesity: Challenge for gastroenterologists”

David H Van Thiel, Rush University Medical Center, USA on the topic, “Hepatitis C eradication: A promise unfulfilled”

Bashar Attar, Cook County Health and Hospitals System, USA on the topic, “Subclinical exocrine pancreatic insufficiency (EPI): A disease that merits treatment”

Giovanni Gasbarrini, Catholic University of Rome, Italy on the topic, “Gut Microbiota: An epochal revolution”

The Special session for the Conference was carried out through Workshops:

Raihan A S M A, Bangabandhu Sheikh Mujib Medical University, Bangladesh on the topic, “Genotype pattern of H. pylori in gastritis and peptic ulcer disease in relation to normal endoscopic findings”

Anisur Rahman, Sher -E - Bangla Medical College, Bangladesh on the topic, “Comparison of results of rapid urease test (RUT) and PCR after Helicobacter pylori (H. pylori) eradication therapy in peptic ulcer disease patients at a medical university hospital”

Raihan A S M A, Bangabandhu Sheikh Mujib Medical University, Bangladesh on the topic, “Association of Helicobacter pylori and anaemia”

Siddique Abu Raihan, Sheikh Sayera Khatun Medical College, Bangladesh on the topic, “Comparison of efficacy of four different Helicobacter pylori eradication regimens in peptic ulcer disease patients at a Medical University Hospital”

The conference proceedings were carried out through various scientific sessions and plenary lectures:

Title: Childhood colitis aggravates gut barrier impairment via miR-196 when exposed to another episode of inflammation in adult-life by Qingjie Li, The University of Texas, USA

Title: Gut bacteria and Metabolism: Examining host-microbe cross talk in the disease state by Susan Joyce, APC Microbiome Ireland - University College of Cork, Ireland

Title: Acute pancreatitis in early childhood by Biljana VuletiÄ‡, University of Kragujevac, Serbia

Title: Estimation of efficacy of haemodialysis in patients with Helicobacter pylori infection before and after eradication therapy by Nany El Gayar, Alexandria University, Egypt

Title: The influence of diet, bacteria and bacterial metabolites on epithelial cell responses in intestinal inflammation and cancer by Silvia Melgar, APC Microbiome Ireland - University College of Cork, Ireland

Title: Gluten related diseases by Biljana VuletiÄ‡, University of Kragujevac, Serbia

Title: Laser sphincterotomy: a minimally invasive treatment for severe anal spasm in cases of chronic anal fissures by Jaya Maheshwari, Jyoti Hospital, India

Title: Successful treatment of chronic Hepatitis C infection in Republic of Srpska by Jelena Petkovic Dabic, University Clinical Centre of the Republic of Srpska, Bosnia and Herzegovina

Title: Vedolizumab for Inflammatory Bowel Disease: for now only rescue therapy in the Republic of Srpska by Renata Tamburic, University Clinical Centre of the Republic of Srpska, Bosnia and Herzegovina

Title: Association of nontuberculous mycobacteria (NTM) with Crohn's disease (CD) by Raihan A S M A, Bangabandhu Sheikh Mujib Medical University, Bangladesh

Title: The effectiveness of the new method of radial sphincterotomy by Kenan Yusif Zade, Military Hospital of State Border Service, Azerbaijan

Title: The relationship between Rh and ABO Blood Groups distribution and the incidence of gastric cancer and peptic ulcer disease: Case-control study by Ziad Aljarad, Aleppo University Hospital, Syria

Conference Series llc LTD has taken the privilege of felicitating Gastro Congress 2018 Organizing Committee and Keynote Speakers who supported and contributed for the success of this event. We are glad to inform that all accepted abstracts for the conference have been indexed in Conference Series llc LTD Journal, Journal of Gastrointestinal & Digestive System as a special issue.

We sincerely thank the Organizing Committee Members, Participants and Media Partners for their gracious presence and generous support, without which the conference would not have reached the pinnacle of success. With the unique feedback from the conference, Conference Series llc LTD would like to announce the commencement of the “14^th Euro-Global Gastroenterology Conference” during July 08-09, 2019 at Zürich, Switzerland.

Let us meet again @ Gastro Congress 2019

Sophia Williams, Event Director

Gastro Congress-2019, Rome, Italy

47 Churchfield Road, London, W3 6AY

Email: gastrocongress@gastroconferences.com; gastrocongress@gastrospeakerexperts.org

Customer Service: +44-0-800-014-8923

GASTRO CONGRESS 2019 MARKET ANALYSIS

Gastroenterology is the branch of medicine Related to the GI tract (stomach and intestines) and the accessory organs of digestion (from the mouth to the anus).Focused on the digestive system and its disorders. Some of the conditions treated under this specialty include but are not limited to: Crohnâ€™s disease, Gastroesophageal reflux disease (GERD), inflammatory bowel disease, irritable bowel syndrome, peptic ulcer disease, celiac disease, colon cancer, heartburn, gastric cancer, diverticulitis, and ulcerative colitis.

Gastrointestinal diseases refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas.

Fg: Mostly Affected Gastroenterology diseases

The global gastrointestinal therapeutics market size is expected to reach USD 65.1 billion by 2025, according to a new report by Grand View Research, Inc., registering a 6.6% CAGR during the forecast period. Growing geriatric population prone to gastrointestinal indications is one of the key factors anticipated to contribute to market growth. According to a report by WHO, colon cancer caused nearly 694,000 deaths in 2014.

Fg : Gastroenterology market size,2017-2025 65.1 (USD billion) by 2025

A wide range of new generation therapeutics targets that include novel small molecules and cellular therapy are currently under investigation. These include tofacitinib, ustekinumab, mongersen, and vedolizumab. This influx is anticipated to be a consequence of high prevalence of gastrointestinal diseases globally. Vedolizumab is emerging as a first-line biologic therapy for Crohnâ€™s disease. Currently, the U.S. FDA has approved Humira, Amjevita, Cimzia, Remicade, Renflexis, Inflectra, Tysabri, and Entyvio for the treatment of Crohnâ€™s disease.

Some studies have indicated that biologics exhibit greater long-term efficiency. According to a study conducted by University of Chicago, usage of biologics has resulted in an overall decrease in the number of surgeries by approximately 40.0%, emergency room visits by 60.0%, and hospitalizations by 50.0%.

Similarly, the National Institute carried out a study on effectiveness of infliximab in treatment for Health Research and it was reported to be a cost-effective solution in episodic treatment of active Crohnâ€™s Disease. Increasing need for cost containment in drug development as well as administration costs is likely to fuel growth opportunities for biologics. Advent of targeted treatment alternatives has led to development of more personalized biologics.

Top Gastroenterology companies

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	July 08-09-2019
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2
Poster Opportunity Closed	Click Here to View